1. Home
  2. MKTX vs ICUI Comparison

MKTX vs ICUI Comparison

Compare MKTX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketAxess Holdings Inc.

MKTX

MarketAxess Holdings Inc.

SELL

Current Price

$164.15

Market Cap

4.6B

Sector

Finance

ML Signal

SELL

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

N/A

Current Price

$160.52

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MKTX
ICUI
Founded
2000
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.0B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
MKTX
ICUI
Price
$164.15
$160.52
Analyst Decision
Hold
Buy
Analyst Count
12
8
Target Price
$158.00
★ $193.38
AVG Volume (30 Days)
★ 734.9K
216.3K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 1.90%
N/A
EPS Growth
N/A
★ 100.62
EPS
★ 4.13
1.96
Revenue
$397,471,000.00
★ $2,231,262,000.00
Revenue This Year
$5.71
N/A
Revenue Next Year
$6.80
$4.44
P/E Ratio
★ $39.76
$80.19
Revenue Growth
★ 7.45
N/A
52 Week Low
$108.75
$112.50
52 Week High
$195.97
$192.85

Technical Indicators

Market Signals
Indicator
MKTX
ICUI
Relative Strength Index (RSI) 80.44 48.28
Support Level $163.18 $152.02
Resistance Level $165.87 $167.67
Average True Range (ATR) 0.34 4.26
MACD -0.51 0.56
Stochastic Oscillator 86.07 66.40

Price Performance

Historical Comparison
MKTX
ICUI

About MKTX MarketAxess Holdings Inc.

Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: